ASRM will utilize this endowment to create, establish, and maintain innovative educational programs for healthcare professionals who are actively enrolled in training for the field of reproductive ...
InvestorsHub on MSN
Femasys to showcase FemaSeed fertility treatment at ASRM 2026 as commercialization strategy expands
Femasys will present its fertility treatment and diagnostic portfolio at the ASRM 2026 Scientific Congress & Expo, highlighting its efforts to expand adoption across OB/GYN practices and reproductive ...
ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of ...
SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
Please provide your email address to receive an email when new articles are posted on . The ASRM Scientific Congress & Expo will take place Oct. 14 to 18 in New Orleans. The theme of the meeting is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results